We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Transcept to Fund Intermezzo Analyses With Staff Cut
Transcept to Fund Intermezzo Analyses With Staff Cut
July 22, 2011
Transcept Pharmaceuticals is slashing 45 percent of its employees in response to a second FDA complete response letter on its insomnia drug Intermezzo calling for further investigation into the drug’s safety.